These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15923412)
1. Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials. Gebbia V; Galetta D; De Marinis F Ann Oncol; 2005 May; 16 Suppl 4():iv123-131. PubMed ID: 15923412 [No Abstract] [Full Text] [Related]
2. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung. Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691 [No Abstract] [Full Text] [Related]
3. Advanced non-small cell lung cancer (ANSCLC): new chemotherapy phase II studies and old faults. Tummarello D; Graziano F Lung Cancer; 1996 Nov; 15(3):375-6. PubMed ID: 8959682 [No Abstract] [Full Text] [Related]
5. [Treatment of inoperable non-small cell lung cancer: induction chemotherapy or hyperfractionated radiotherapy? Apropos of 2 recent therapeutic trials]. Reboul F; Vincent P; Chauvet B; Brewer Y; Taulelle M Cancer Radiother; 1998; 2(3):287-9. PubMed ID: 9749128 [No Abstract] [Full Text] [Related]
6. Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter? Di Maio M; Bria E; Rossi A; Perrone F Ann Oncol; 2008 Feb; 19(2):402-3. PubMed ID: 18180243 [No Abstract] [Full Text] [Related]
7. Non small cell lung cancer and chemotherapy. Nardini S Monaldi Arch Chest Dis; 1994 Apr; 49(2):177-8. PubMed ID: 8049706 [No Abstract] [Full Text] [Related]
8. There and back again: An immunotherapy tale. Guo Y; Krupnick AS J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1771-1774. PubMed ID: 29409610 [No Abstract] [Full Text] [Related]
9. [Taxol in bronchial carcinoma]. Gatzemeier U Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171 [No Abstract] [Full Text] [Related]
10. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers]. Le Chevalier T Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932 [No Abstract] [Full Text] [Related]
11. Missing patient-reported outcome data in an adjuvant lung cancer study. Land SR J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601 [No Abstract] [Full Text] [Related]
13. Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group study. Chapman R; Crowley J; Lucas JG; Hom BL; Livingston RB; Vaughn CB; Hynes HE Invest New Drugs; 1993 Feb; 11(1):91-2. PubMed ID: 8394299 [No Abstract] [Full Text] [Related]
14. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
15. Comment on Rosell et al., Roth et al. and Gandara et al., Lung Cancer. Grannis FW Lung Cancer; 2000 Jun; 28(3):247-51. PubMed ID: 10917719 [No Abstract] [Full Text] [Related]
16. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all. Schiller JH; Ramalingam SS J Clin Oncol; 2009 Jul; 27(20):3265-7. PubMed ID: 19470911 [No Abstract] [Full Text] [Related]
17. The management of PS2 patients with advanced non-small cell lung cancer. Cheong KA; Chrystal K; Harper PG Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572 [TBL] [Abstract][Full Text] [Related]